|*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions. |
My wife had an adenocarcinoma that had moved outside of the pancreas and was dangerously close to the portal vein and the superior mesenteric vein and artery. In order to get her Whipple surgery the tumor had to be shrunk away from these veins and arteries. After four cycles of Folfirinox, CT Scan showed no shrinkage. After fourth cycle my wife started taking an epigenetic supplement in conjunction with her chemotherapy. By the end of her eighth cycle, two months later, CT Scan showed a 75% shrinkage making her eligible for her Whipple surgery. She ended chemo on Nov.18,2015 after 8 cycles but continued to take her supplement. On Dec. 23, 2015, after a routine stent replacement surgery, the medical oncologist in the hospital told her that her tumor had shrunk an additional 24%. That is almost an 82% reduction in a matter of several months.
Based on the epigenetic properties of the supplement she takes and its
effects on cancer cells I believe that it played an instrumental role in the
shrinkage of her tumor. This is why I am asking the question. Is 82%
shrinkage of an adenocarcinoma after 8 cycles of Folfirinox common or not?
What do most people experience? What is the average shrinkage one might
Reply to this message | Return to Main Message List